Jun 16, 2025EconomicsReverse Split, Forward Motion: Shuttle Pharma Plans to Fuel Cancer Innovation by Shrinking SharesShuttle Pharmaceuticals (NASDAQ: SHPH) announced a critical strategic decision on Thursday.
May 21, 2025FundingBristol Myers Squibb’s $40B U.S. Investment Signals a Strategic Bet on Domestic ManufacturingAs global pharmaceutical supply chains face renewed scrutiny and U.S. healthcare costs continue to climb, Bristol Myers Squibb (BMS) is making a bold and strategic move: a $40 billion investment in U.S.-based manufacturing over the next decade.
